Ratio 125%: reformulate [RSABE / ABEL]

posted by drsinghs – India, 2012-05-10 07:49 (4753 d 07:01 ago) – Posting: # 8549
Views: 7,651

❝ If your observed T/R ratio is 125 %, your chances to get a 90 % CI within 80.00 - 125.00 % in the next study, even with a replicate design, are close to nil.


Thanks ohlbe,

Can I once again request you to please comment on my other query as below?

This is regarding a Modified release HVDP. If I check same batch of test and reference by both 2 way crossover and replicate design, what kind of differences in results can I expect? Basically I want to understand the impact of change in study design on BE results.

Thanks & regards,
drsinghs

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
62 visitors (0 registered, 62 guests [including 39 identified bots]).
Forum time: 14:50 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5